International patients can access clinical trials abroad, but a trial is medical research with uncertain benefit and no guaranteed outcome, and every step should be taken alongside your own treating oncologist. If you want to compare accredited options, you can browse verified providers here.
This article explains what clinical trials are, how they are overseen, how international patients can find and access them, and the practical and cost realities easy to underestimate. The goal is to help you ask better questions, not to raise false hope. A trial can be a thoughtful option for some patients, but it is never a cure you can buy, and never a substitute for the care your own doctors coordinate.
What a Clinical Trial Actually Is
A clinical trial is a carefully designed research study that tests whether a treatment, device, or strategy is safe and whether it works better than what is already available. Because a trial is research, the answer is not known in advance. That uncertainty is the point: the treatment being studied may work, may not help, or may carry side effects not yet fully understood.
Trials are usually described by phase, and the phases help set realistic expectations:
- Phase 1: small studies focused mainly on safety, dosing, and how the body handles a treatment. Individual benefit is not the aim.
- Phase 2: studies that begin to measure whether the treatment has an effect against a condition, while watching safety.
- Phase 3: larger studies comparing the new approach against the current standard of care, often across many countries.
- Phase 4: studies done after approval, tracking longer-term safety and real-world results.
Two protections sit at the heart of any legitimate trial. The first is informed consent: you must be told, in language you understand, what the study involves, the known and possible risks, the alternatives including standard treatment, and your right to leave at any time without losing your usual care. The second is ethical oversight by an independent review board or ethics committee that reviews the study before it opens and monitors it as it runs. A trial you cannot verify, or one with no identifiable oversight, is not one to trust.
How International Patients Can Find and Access Trials
Legitimate trials are registered in public databases, which is the honest starting point. Major registries list the study, its phase, its eligibility criteria, the sites running it, and contact details. Because many Phase 3 oncology trials run across multiple countries, a study may be recruiting at a hospital abroad, which is where international access becomes possible. Access then tends to follow a few steps:
- Your treating oncologist reviews your diagnosis, prior treatments, and health, then helps identify trials for which you might qualify.
- You or your care team contact the trial site, often an academic or research hospital, through its research office or international services.
- The site confirms whether the trial is open, whether it accepts patients from abroad, and what documentation it needs, such as pathology reports, imaging, and treatment history.
- Screening tests determine final eligibility; many interested patients do not qualify, and that is normal.
Eligibility criteria exist for safety and research integrity, so they are strict and non-negotiable. Cancer type and subtype, stage, genetic or molecular markers, prior therapies, organ function, and overall fitness can all decide whether a trial is open to you. Being turned away from one study does not mean no option exists; it means that protocol was not a match.
The Practical and Cost Realities
This is where honesty matters most. In many trials, the treatment under study may be provided at no charge because the sponsor supplies it, but that does not mean the experience is free. Travel, accommodation, visas, screening tests, routine care outside the protocol, and management of complications are usually the patient's responsibility, and for a trial abroad these add up quickly. Rather than fixed figures, think in ranges: screening and travel alone can reach the mid single-digit thousands of US dollars or more, and a long or repeated-visit protocol multiplies it.
Ask any prospective site, in writing, what the study covers and what it does not, whether repeat visits are required, what happens if you have a serious side effect abroad, and what care is available if the trial ends or you leave it. A clear, documented answer is a good sign; vagueness is not.
One warning deserves emphasis. Be very cautious of any clinic or broker that charges large fees to let you join a study while promising access or a result. Legitimate trials do not sell guaranteed outcomes, and pay-to-participate schemes that frame unproven, unregistered interventions as trials are a known way desperate patients are exploited. If someone guarantees a cure, downplays risks, cannot point you to a registration and an ethics committee, or pressures you to pay up front, stop and consult your own oncologist.
MTA-Verified Providers With Oncology and Research Capability
The following MTA-verified hospitals are established oncology destinations that serve international patients. Trial availability changes constantly and depends on your diagnosis, so treat these as starting points for a conversation, verified through your own care team, not a promise that a trial is open to you.
Apollo Hospitals Enterprise Limited - MTA Verified
Chennai, India
- Location: Chennai, India
- Focus: Large multi-specialty hospital group and a major oncology destination.
- Languages: English and regional Indian languages.
- International services: Established services covering coordination, documentation, and logistics.
Best for: patients seeking a high-volume oncology center with broad specialty support.
View Apollo Hospitals Enterprise Limited on Better by MTA
Bumrungrad International Hospital - MTA Verified
Bangkok, Thailand
- Location: Bangkok, Thailand
- Focus: JCI-accredited international hospital with broad oncology capability.
- Languages: English and Thai.
- International services: Extensive services for overseas patients, including records review and visit planning.
Best for: patients who want an internationally accredited hospital with strong cross-border care.
View Bumrungrad International Hospital on Better by MTA
Humanitas Research Hospital - MTA Verified
Rozzano, Milan, Italy
- Location: Rozzano, Milan, Italy
- Focus: Academic research hospital with active oncology research.
- Languages: English and Italian.
- International services: International patient support within an academic, research-oriented setting.
Best for: patients drawn to an academic center where oncology research is part of clinical work.
View Humanitas Research Hospital on Better by MTA
King Faisal Specialist Hospital & Research Centre - MTA Verified
Riyadh, Saudi Arabia
- Location: Riyadh, Saudi Arabia
- Focus: Leading specialist research hospital with advanced oncology services.
- Languages: English and Arabic.
- International services: International patient coordination within a specialist research institution.
Best for: patients seeking a specialist research hospital with advanced, subspecialized care.
View King Faisal Specialist Hospital & Research Centre on Better by MTA
King's College Hospital Dubai - MTA Verified
Dubai, United Arab Emirates
- Location: Dubai, United Arab Emirates
- Focus: UK-affiliated hospital with oncology services.
- Languages: English and Arabic.
- International services: International patient services with a UK clinical affiliation.
Best for: patients who value a UK-affiliated hospital with English-language care in a central travel hub.
View King's College Hospital Dubai on Better by MTA
Burjeel Medical City - MTA Verified
Abu Dhabi, United Arab Emirates
- Location: Abu Dhabi, United Arab Emirates
- Focus: Quaternary hospital with comprehensive oncology services.
- Languages: English and Arabic.
- International services: International patient support within a quaternary care setting.
Best for: patients needing comprehensive, high-complexity oncology care with international coordination.
View Burjeel Medical City on Better by MTA
How to Choose a Trial and a Provider
Choosing well is mostly about verification and keeping your own medical team at the center of every decision:
- Confirm the trial is registered in a public registry and has identifiable ethics-committee or review-board oversight.
- Review the full informed consent document, and be sure you understand the phase, the risks, the alternatives, and your right to withdraw.
- Ask in writing what the study covers and what it does not, including travel, screening, repeat visits, and care for complications.
- Treat any large upfront fee for access, or any guarantee of a cure or result, as a serious warning sign and discuss it with your oncologist.
- Have your treating oncologist review eligibility and the protocol, so the decision fits your overall care plan, and when you are ready to compare options side by side, get a free quote through Better by MTA.
Ready to Explore Your Options?
Start by gathering information and bringing it back to the doctors who already know your case. A clinical trial abroad can be worth exploring for some patients, but only as a researched, physician-guided step with realistic expectations and no promise of an outcome. Let your treating oncologist help you weigh whether a trial is a sound fit, and verify every claim before you commit.
Better by MTA helps you compare verified providers, request quotes, and coordinate care with confidence, powered by Mastercard payment infrastructure and compliant with HIPAA, GDPR, and SOC 2 standards, so your information and payments are handled securely from first inquiry to follow-up.
By Jonathan Edelheit, CEO and Co-Founder, Medical Tourism Association. Last updated October 2026.
.png)
